Provided by Tiger Trade Technology Pte. Ltd.

Ecopetrol SA

18.26
+0.52002.93%
Volume:1.35M
Turnover:24.60M
Market Cap:37.54B
PE:9.60
High:18.38
Open:17.68
Low:17.68
Close:17.74
52wk High:18.38
52wk Low:8.57
Shares:2.06B
Float Shares:237.00M
Volume Ratio:1.01
T/O Rate:0.57%
Dividend:0.99
Dividend Rate:5.43%
EPS(TTM):1.90
EPS(LYR):1.16
ROE:15.95%
ROA:7.31%
PB:1.83
PE(LYR):15.68

Loading ...

Lundbeck presents new data at AAN 2026 highlighting real-world changes in migraine-related cognitive symptoms after starting VYEPTI® (eptinezumab)

prnewswire
·
Apr 20

Ecopetrol Anticipates Copoazú-1 Well Test Results by End of June

Deep News
·
Apr 18

Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)

GlobeNewswire
·
Apr 13

Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026

GlobeNewswire
·
Apr 09

Ecopetrol Board Approves President's Unpaid Leave of Absence

MT Newswires Live
·
Apr 07

Market Chatter: Ecopetrol Grants CEO Ricardo Roa Extended Holiday, Unpaid Leave of Absence

MT Newswires Live
·
Apr 07

Ecopetrol Receives Approval for $1.25 Billion Loan to Refinance Debt

MT Newswires Live
·
Apr 06

Rhythm Pharmaceuticals Announces Changes to Board of Directors

GlobeNewswire
·
Apr 03

EURneffy 1 mg approved across the EU as the first and only needle-free adrenaline treatment for young children (≥15 kg) at risk of anaphylaxis

GlobeNewswire
·
Mar 31

China Securities: Profitability in VC and EC Segments Expected to Improve, Focus on High-Beta Stocks

Stock News
·
Mar 30

588-unit Pinery Residences sells 92.5% of units at over $2,500 psf average on launch day

Gerine Tang Yi Qian
·
Mar 28

Rhythm Pharmaceuticals Receives Positive CHMP Opinion for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or Impairment

GlobeNewswire
·
Mar 26

Shrinking EUA supply puts EU ETS under policy strain

Fastmarkets
·
Mar 26

Ecopetrol Says No Violations, Contract Breaches to Date Related to Formal Charges Against President Ricardo Roa

MT Newswires Live
·
Mar 26

Ecopetrol says ‘committed’ to safeguarding interests of company, shareholders

TIPRANKS
·
Mar 25

EC urged to stop Fifa’s ‘aggressive and exploitative’ World Cup ticket prices

cityam
·
Mar 24

Ecopetrol price target raised to $13 from $8.70 at Goldman Sachs

TIPRANKS
·
Mar 23

Press Release: Henlius Reports 2025 Results: Sustained Growth in Both Revenue and Profit, Advancing Innovation Validation and Global Operations

Dow Jones
·
Mar 20

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity

GlobeNewswire
·
Mar 20